A quick test for detecting HIV RNA without needing to prepare samples
A Rapid HIV RNA Detection without Sample Preparation
This study is working on a quick and easy test that lets people check for HIV directly from their blood at home or in pharmacies, making it especially helpful for those in areas where healthcare resources are limited.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Crosslife Technologies, INC. NIH-funded |
| Lab location | 1 site (Carlsbad, United States) |
| Project ID | NIH-10926868 on NIH RePORTER |
What this research studies
This research aims to develop a rapid and sensitive test for detecting HIV RNA directly from unprocessed blood samples. By utilizing innovative chemistry and automated technology, the test will allow individuals to diagnose HIV infections and monitor viral loads conveniently at home or in pharmacies. The project is divided into two phases: the first focuses on developing and optimizing the technology, while the second phase involves validating the test with clinical samples. This approach is particularly beneficial for areas with limited resources where HIV is prevalent.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of HIV infection or those currently undergoing treatment who need regular monitoring.
Not a fit: Patients who are not at risk of HIV or those who are already receiving effective treatment and monitoring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a simple and effective way for patients to diagnose HIV and monitor their treatment from home.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for HIV, but this specific approach is innovative and aims to improve accessibility and sensitivity.
Where this research is happening
Carlsbad, United States
- Crosslife Technologies, INC. — Carlsbad, United States (Active)
Researchers
- Principal investigator: Cho, Hyundae — Crosslife Technologies, INC.
- Study coordinator: Cho, Hyundae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.